Publications

Journal Article
Multicenter Study
Epublish
Electronic publication date
December 8, 2025

View on Pubmed.gov 41356096 | View on doi.org 10.5334/gh.1496

Immunization and Cardiovascular Disease in Latin America. The CorVacc Study: Results.

Search for publications in this journal Glob Heart - 20(1):108

Corvacc Study Investigators

Abstract

INTRODUCTION

Immunization rates against influenza and pneumococcus in Latin America remain lower than expected, particularly in Andean region, Central America, Mexico, and Caribbean region. An incremental correlation between economic strata and educational level and vaccines uptake has been observed. This highlights the need for more comprehensive data to accurately characterize the current health landscape and develop strategies for improvement.

METHODS AND DESIGN

The Inter-American Registry of Influenza and Pneumococcal Vaccination (CorVacc Study) is a cross-sectional survey of the general population conducted across 19 Latin American countries. Adults aged 18 years and older completed a 34-question online survey. The pool was validated within the first 1000 responses. Data were grouped into seven categories: demographics, socioeconomic and educational level, cardiometabolic profile, cardiovascular interventions, medical follow-up and treatments, and COVID-19 vaccination status.

RESULTS

A total of 21,389 responses were obtained, distributed as follows: 8915 from the North, Central, and Caribbean region; 7492 from the Andean region; and 4801 from the Southern Cone region. Influenza vaccination rates were lower in the Andean region (OR: 0.62; 95% CI: 0.50-0.78), the Caribbean (OR: 0.30; 95% CI: 0.23-0.39), and Central America (OR: 0.59; 95% CI: 0.46-0.76) compared with the Southern Cone. Residing in Central America (OR: 3.06; 95% CI: 1.62-5.77) was associated with greater pneumococcal vaccination. The probability of being vaccinated against influenza was higher in men (OR: 1.3; 95% CI: 1.1-1.6) and in individuals with obesity (OR: 1.26; 95% CI: 1.13-1.40). COPD was associated with a lower probability of pneumococcal vaccination (OR: 0.51; 95% CI: 0.33-0.79).

CONCLUSIONS

This study highlights the importance of targeted vaccination campaigns to improve coverage, particularly in regions with lower rates. It also underscores the need for enhanced education and awareness of the benefits of vaccination. Tackling barriers such as vaccine hesitancy and misinformation will be essential for raising vaccination rates and, ultimately, for reducing the burden of cardiovascular disease.

References

Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, Mente A, Yusuf S. Reducing the global burden of cardiovascular disease, part 1: The epidemiology and risk factors. Circulation Research. 2017;121:677–694. DOI: 10.1161/CIRCRESAHA.117.308903

Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. The Lancet Infectious Diseases. 2009;9:601–610. DOI: 10.1016/S1473-3099(09)70233-6

Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: Case-control study through a general practice database. European Heart Journal. 2008;29:96–103. DOI: 10.1093/eurheartj/ehm516

Kwok CS, Aslam S, Kontopantelis E, Myint PK, Zaman MJ, Buchan I, Loke YK, Mamas MA. Influenza, influenza-like symptoms and their association with cardiovascular risks: A systematic review and meta-analysis of observational studies. International Journal of Clinical Practice. 2015;69:928–937. DOI: 10.1111/ijcp.12646

Conflict of interest statement

The authors have no competing interests to declare.

MeSH

Specialties

Substances

Copyright

Copyright: © 2025 The Author(s).